Author

Atul Pranay

Oklahoma Medical Research FoundationORCID 0009-0006-3149-7437Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Biochemistry· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:drug response / drug discovery· 1 Research Focus:metabolism & bioenergetics· 1 Assay:metabolomics· 1 Organism:mouse· 1

Frequent Co-Authors

Anna FaakyeiD· 2 shared Kenneth Michael HumphriesiD· 2 shared Satoshi MatsuzakiiD· 2 shared Craig A. Eyster· 1 shared Jennifer R. Giorgione· 1 shared Jie ZhuiD· 1 shared Kylene M. HaroldiD· 1 shared Mostafa H. AhmediD· 1 shared

Activity by Year

2025-2025 · peak 2/yr

Co-Author Collaboration Network

8 top collaborators · 22 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersBiochemistry

Anna FaakyeORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

BiochemistryJournal of the American Heart AssociationPeer-reviewedNov 12, 2025

PFKFB2 is Pivotal for Metabolic Flexibility and Differential Glucose Utilization

Kylene M. Harold, Satoshi Matsuzaki, Atul Pranay…·Kenneth Michael Humphries

This study investigates the role of PFKFB2 in cardiac metabolic flexibility and glucose utilization, finding that its loss impairs mitochondrial function and affects systemic glucose homeostasis under stress.

6 citations

mousemetabolomics

𝕏 PostBluesky

BiochemistryPLoS ONEPeer-reviewedMay 22, 2025

Mechanistic studies of PFKFB2 reveals a novel inhibitor of its kinase activity

Craig A. Eyster, Satoshi Matsuzaki, Atul Pranay…·Kenneth Michael Humphries

The paper identifies and validates a new inhibitor, B2, of PFKFB2 kinase activity through enzymatic assays and metabolic profiling in A-498 cells.

4 citations

experimental assaydrug response / drug discovery

𝕏 PostBluesky